By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Upsher-Smith Laboratories, Inc. 

14905 23rd Avenue North

Minneapolis  Minnesota  55447  U.S.A.
Phone: 800-328-3344 Fax:


Company News
Upsher-Smith Laboratories Honors 45 Innovative Pharmacists From Across The Nation 2/24/2015 10:24:58 AM
Upsher-Smith Laboratories's Vogelxo (Testosterone) Gel 1% (Tubes and Packets) Receives AB-Rating To Testim From FDA 2/10/2015 11:34:28 AM
Upsher-Smith Laboratories Launches Patient Savings And Support Program For Qudexy XR (Topiramate) Extended-Release Capsules 2/9/2015 9:45:32 AM
Upsher-Smith Laboratories Release: Systematic Review Presented At 68th Annual Meeting Of The American Epilepsy Society Points To Need For Expert Consensus On Seizure Cluster Nomenclature And Diagnosis 12/8/2014 9:01:30 AM
Upsher-Smith Laboratories Presents New Data From Year-Long, Open-Label Extension Study Of Qudexy XR (Topiramate) Extended-Release Capsules At 68th Annual American Epilepsy Society Meeting 12/8/2014 8:59:45 AM
Upsher-Smith Laboratories To Present New Data At 2014 American Epilepsy Society Annual Meeting 11/25/2014 10:54:40 AM
Upsher-Smith Laboratories, In Conjunction With National Epilepsy Awareness Month, Launches New Website For People Affected By Seizure Clusters, A Rare Seizure Pattern 11/3/2014 9:08:45 AM
Upsher-Smith Laboratories Presents New Data On The Administration Of Qudexy™ XR (Topiramate) Extended-Release Capsules Through Enteral Feeding Tubes 10/23/2014 9:21:53 AM
The Upsher-Smith Laboratories Galaxy™ Portfolio Of Antiepileptic Drugs Now Available 7/28/2014 8:22:53 AM
Upsher-Smith Laboratories Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules 7/14/2014 9:44:32 AM